Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update. Issue 3 (3rd May 2020)

• Record Type: Journal Article
• Authors: Kobayashi, Ichiro; Akioka, Shinji; Kobayashi, Norimoto; Iwata, Naomi; Takezaki, Shunichiro; Nakaseko, Haruna; Sato, Satoshi; Nishida, Yutaka; Nozawa, Tomo; Yamasaki, Yuichi; Yamazaki, Kazuko; Arai, Satoru; Nishino, Ichizo; Mori, Masaaki
• Is Part Of: Modern rheumatology. Volume 30:Issue 3(2020)
• Page Start: 411
• Page End: 423
• Publication Date: 2020-05-03
• Subjects: Diagnosis -- pathophysiology -- management -- interstitial lung disease -- myositis-specific autoantibodies; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1080/14397595.2020.1718866
• Languages: English
• ISSNs: 1439-7595

Abstract

Abstract: Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of 'Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 'consisting of a review of articles in the field and evidence-informed consensus-based experts' opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by 'Research on rare and intractable diseases, Health and Labor Sciences Research Grants'. This article is a digest version of the Japanese guidance.